REPAIRome specifically addresses the repair of one of the most serious types of DNA damage, DNA double-strand breaks (DSBs).
New data from Spherix Global Insights uncover how hematologists are defining the “right patient” for gene therapy, balancing promise with practical barriers in sickle cell disease, thalassemia, and ...
CRISPR therapies offer precise gene-editing solutions for treating genetic disorders and other complex diseases. Rising prevalence of genetic conditions drives adoption, and emerging CRISPR-based ...
Cardiologist Dr. Dmitry Yaranov, widely known as @heart_transplant_doc, has outlined what he calls the “crazy future of heart ...
Katy Rezvani, MD, PhD, discusses advancements in CAR-NK cell therapy, focusing on enhancing antitumor efficacy while ensuring safety through precise gene editing techniques.
Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.
The clinical success of CRISPR-based treatments is fundamentally dependent on sophisticated gRNA targeting systems that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback